Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Shares Issued (2018 - 2025)

Serina Therapeutics (SER) has disclosed Shares Issued for 7 consecutive years, with -$10000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 100.2% to -$10000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Sep 2025, up 4574.29% year-over-year, with the annual reading at $5.0 million for FY2024, 33153.33% up from the prior year.
  • Shares Issued hit -$10000.0 in Q4 2025 for Serina Therapeutics, down from $10000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $5.0 million in Q2 2024 to a low of -$4.9 million in Q2 2025.
  • Historically, Shares Issued has averaged $549800.0 across 4 years, with a median of $12500.0 in 2023.
  • Biggest YoY gain for Shares Issued was 32553.33% in 2024; the steepest drop was 489700.0% in 2024.
  • Year by year, Shares Issued stood at $496000.0 in 2021, then plummeted by 96.98% to $15000.0 in 2023, then skyrocketed by 32553.33% to $4.9 million in 2024, then plummeted by 100.2% to -$10000.0 in 2025.
  • Business Quant data shows Shares Issued for SER at -$10000.0 in Q4 2025, $10000.0 in Q3 2025, and -$4.9 million in Q2 2025.